Taztia xt and Depression aggravated - a phase IV clinical study of FDA data

Summary:

Depression aggravated is reported as a side effect among people who take Taztia xt (diltiazem hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Ambien, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Depression aggravated when taking Taztia xt. It is created by eHealthMe based on reports of 592 people who have side effects when taking Taztia xt from the FDA, and is updated regularly.

What is Taztia xt?

Taztia xt has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 621 Taztia xt users. Check the latest studies of Taztia xt.

What is Depression aggravated?

Depression aggravated is found to be associated with 2,417 drugs and 750 conditions by eHealthMe. Check the latest studies of Depression aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

592 people reported to have side effects when taking Taztia xt.
Among them, 28 people (4.73%) have Depression aggravated.

Could Taztia xt cause Depression aggravated?

Among these 28 people:

How long have people been on Taztia xt when they have Depression aggravated? *

What is the gender of people who have Depression aggravated when taking Taztia xt? *

female: 84 %
male: 16 %

What is the age of people who have Depression aggravated when taking Taztia xt? *

What are other drugs people take besides Taztia xt? *

What are other side effects people have besides Depression aggravated? *

Pain: 11 people, 39.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 35.71%
Fatigue (feeling of tiredness): 10 people, 35.71%
Sinusitis (inflammation of sinus): 9 people, 32.14%
Stress And Anxiety: 8 people, 28.57%
Back Pain: 7 people, 25.00%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 25.00%
Pain In Extremity: 6 people, 21.43%
Hair Loss: 6 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 21.43%

What are the existing conditions these people have? *

High Blood Cholesterol: 7 people, 25.00%
Pain: 5 people, 17.86%
Diabetes: 4 people, 14.29%
Osteoporosis (bones weak and more likely to break): 4 people, 14.29%
Mood Swings (an extreme or rapid change in mood): 3 people, 10.71%
Muscle Spasms (muscle contraction): 3 people, 10.71%
Bipolar Disorder (mood disorder): 3 people, 10.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.71%
Hypersensitivity: 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Taztia xt and have Depression aggravated?

- Check whether Depression aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taztia xt:

Taztia xt (621 reports)

Browse all side effects of Taztia xt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression aggravated:

Depression aggravated (2,417 drugs)

Browse all the conditions that are associated with Depression aggravated:

Depression aggravated (750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Taztia xt) and Taztia xt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.